Skip to content
★ Sign in to follow
TE

Thomas E. Daley

Raptor Pharmaceuticals Corp.Raptor Pharmaceutical Corp
Total declarations
24
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (15 ops.)
€1.2M

Latest filing published 22 Jun 2015 for Raptor Pharmaceutical Corp, €396k.

Insider track record

Disclosed buys
0
Disclosed sells
15
Signal history

No signal scores available.

Thomas E. Daley: trading record in brief

This profile gathers the share dealings of Thomas E. Daley across 2 companies, led by Raptor Pharmaceutical Corp and Raptor Pharmaceuticals Corp. Over a trading history stretching from 17 October 2007 to 18 June 2015, the count stands at 24 filings.

The open-market record consists of 15 sales worth €1.2M, with no purchase. Other entries cover 2 share grants and 3 option exercises. In 2015 alone, the filings show no purchases and 3 sales.

On 22 June 2015 came the latest disclosure, an open-market sale for €396k in Raptor Pharmaceutical Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Thomas E. Daley

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations22 total

22 of 22 declarations